Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children

PLoS Medicine

Volumn 15, Issue 4, 2018, Pages

  Bonifacio, Ezio ^a   Beyerlein, Andreas ^b,c,d   Hippich, Markus ^b,c,d   Winkler, Christiane ^b,c,d   Vehik, Kendra ^e   Weedon, Michael N ^f   Laimighofer, Michael ^b   Hattersley, Andrew T ^f   Krumsiek, Jan ^b   Frohnert, Brigitte I ^g   Steck, Andrea K ^g   Hagopian, William A ^h   Krischer, Jeffrey P ^e   Lernmark, Åke ⁱ   Rewers, Marian J ^g   She, Jin Xiong ^j   Toppari, Jorma ^k,l   Akolkar, Beena ^m   Oram, Richard A ^f,n,o   Rich, Stephen S ^p   Ziegler, Anette G ^b,c,d   more..

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

^f UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^g UNIVERSITY OF COLORADO DENVER   (United States)

^h PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

ⁱ LUND UNIVERSITY HOSPITAL   (Sweden)

^j MEDICAL COLLEGE OF GEORGIA   (United States)

^k TURKU UNIVERSITY HOSPITAL   (Finland)

^l UNIVERSITY OF TURKU   (Finland)

^m NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

ⁿ UNIVERSITY OF ALBERTA   (Canada)

^o Queen Mary University of London and Barts NIHR BRC NHS Trust National Institute for Health and Care Research   (United Kingdom)

^p UNIVERSITY OF VIRGINIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA DQ8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; PANCREAS ISLET CELL ANTIBODY;

ARTICLE; AUTOIMMUNITY; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; PEDIATRICS; PREDICTIVE VALUE; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; FAMILY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; IMMUNOLOGY; METABOLISM; PANCREAS ISLET; RISK ASSESSMENT; RISK FACTOR;

AUTOANTIBODIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INFANT; INFANT, NEWBORN; ISLETS OF LANGERHANS; MALE; RISK ASSESSMENT; RISK FACTORS;

EID: 85046033349     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1002548     Document Type: Article

References (35)

1. Du Toit G, Roberts G, Sayre PH, Bahnson HT, Radulovic S, Santos AF, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015;372:803–13. doi: 10.1056/NEJMoa1414850 25705822
2. Krischer JP, Lynch KF, Schatz DA, Ilonen J, Lernmark Å, Hagopian WA, et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia. 2015;58:980–7. doi: 10.1007/s00125-015-3514-y 25660258
3. Knip M, Åkerblom HK, Becker D, Dosch HM, Dupre J, Fraser W, et al. Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial. JAMA. 2014;311:2279–87. doi: 10.1001/jama.2014.5610 24915259
4. Bonifacio E, Ziegler AG, Klingensmith G, Schober E, Bingley PJ, Rottenkolber M, et al. Effects of high dose oral insulin on immune responses in children at high risk for type 1 diabetes: the Pre-POINT randomized clinical trial. JAMA. 2015;313:1541–9. doi: 10.1001/jama.2015.2928 25898052
5. Vriezinga SL, Auricchio R, Bravi E, Castillejo G, Chmielewska A, Crespo Escobar P, et al. Randomized feeding intervention in infants at high risk for celiac disease. N Engl J Med. 2014;371(14):1304–15. doi: 10.1056/NEJMoa1404172 25271603
6. Lionetti E, Castellaneta S, Francavilla R, Pulvirenti A, Tonutti E, Amarri S, et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N Engl J Med. 2014;371(14):1295–303. doi: 10.1056/NEJMoa1400697 25271602
7. Liu E, Lee HS, Aronsson CA, Hagopian WA, Koletzko S, Rewers MJ, et al. Risk of pediatric celiac disease according to HLA haplotype and country. N Engl J Med. 2014;371(1):42–9. doi: 10.1056/NEJMoa1313977 24988556
8. Bonifacio E, Predicting type 1 diabetes using biomarkers. Diabetes Care. 2015;38(6):989–96. doi: 10.2337/dc15-0101 25998291
9. Näntö-Salonen K, Kupila A, Simell S, Siljander H, Salonsaari T, Hekkala A, et al. Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet. 2008;372(9651):1746–55. doi: 10.1016/S0140-6736(08)61309-4 18814906
10. Rewers M, Bugawan TL, Norris JM, Blair A, Beaty B, Hoffman M, et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia. 1996;39(7):807–12. 8817105
11. Lambert AP, Gillespie KM, Thomson G, Cordell HJ, Todd JA, Gale EA, et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab. 2004;89:4037–43. doi: 10.1210/jc.2003-032084 15292346
12. Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41(6):703–7. doi: 10.1038/ng.381 19430480
13. Winkler C, Krumsiek J, Lempainen J, Achenbach P, Grallert H, Giannopoulou E, et al. A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes. Genes Immun. 2012;13(7):549–55. doi: 10.1038/gene.2012.36 22932816
14. Clayton DG, Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet. 2009;5(7):e1000540. doi: 10.1371/journal.pgen.1000540 19584936
15. Winkler C, Krumsiek J, Buettner F, Angermüller C, Giannopoulou EZ, Theis FJ, et al. Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes. Diabetologia. 2014;57:2521–9. doi: 10.1007/s00125-014-3362-1 25186292
16. Oram RA, Patel K, Hill A, Shields B, McDonald TJ, Jones A, et al. A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults. Diabetes Care. 2016;39(3):337–44. doi: 10.2337/dc15-1111 26577414
17. TEDDY Study GroupThe environmental determinants of diabetes in the young (TEDDY) study: study design. Pediatr Diabetes. 2007;8:286–98. doi: 10.1111/j.1399-5448.2007.00269.x 17850472
18. Insel RA, Dunne JL, Atkinson MA, Chiang JL, Dabelea D, Gottlieb PA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38:1964–74. doi: 10.2337/dc15-1419 26404926
19. Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA. 2013;309(23):2473–9. doi: 10.1001/jama.2013.6285 23780460
20. Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779. doi: 10.1371/journal.pmed.1001779 25826379
21. Wellcome Trust Case Control ConsortiumGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661–78. doi: 10.1038/nature05911 17554300
22. Hagopian WA, Erlich H, Lernmark A, Rewers M, Ziegler AG, Simell O, et al. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421000 infants. Pediatr Diabetes. 2011;12(8):733–43. doi: 10.1111/j.1399-5448.2011.00774.x 21564455
23. Bonifacio E, Yu L, Williams AK, Bingley PJ, Marcovina SM, Adler K, et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. J Clin Endocrinol Metab. 2010;95(7):3360–7. doi: 10.1210/jc.2010-0293 20444913
24. American Diabetes Association (2014) Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14–80.
25. Törn C, Hadley D, Lee HS, Hagopian W, Lernmark Å, Simell O, et al. Role of type 1 diabetes-associated SNPs on risk of autoantibody positivity in the TEDDY study. Diabetes. 2015;64(5):1818–29. doi: 10.2337/db14-1497 25422107
26. Raab J, Haupt F, Scholz M, Matzke C, Warncke K, Lange K, et al. Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study. BMJ Open. 2016;6(5):e011144. doi: 10.1136/bmjopen-2016-011144 27194320
27. Rich SS, Concannon P, Role of type 1 diabetes-associated SNPs on autoantibody positivity in the Type 1 Diabetes Genetics Consortium: overview. Diabetes Care. 2015;38(Suppl 2):S1–3.
28. Evangelou M, Smyth DJ, Fortune MD, Burren OS, Walker NM, Guo H, et al. A method for gene-based pathway analysis using genome wide association study summary statistics reveals nine new type 1 diabetes associations. Genet Epidemiol. 2014;38(8):661–70. doi: 10.1002/gepi.21853 25371288
29. Lenz TL, Deutsch AJ, Han B, Hu X, Okada Y, Eyre S, et al. Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet. 2015;47(9):1085–90. doi: 10.1038/ng.3379 26258845
30. Nejentsev S, Howson JM, Walker NM, Szeszko J, Field SF, Stevens HE, et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature. 2007;450:887–92. doi: 10.1038/nature06406 18004301
31. Hummel S, Pflüger M, Hummel M, Bonifacio E, Ziegler AG, Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care. 2011;34(6):1301–5. doi: 10.2337/dc10-2456 21515839
32. Ziegler AG, Danne T, Dunger DB, Berner R, Puff R, Kiess W, et al. Primary prevention of beta-cell autoimmunity and type 1 diabetes—the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives. Mol Metab. 2016;5(4):255–62. doi: 10.1016/j.molmet.2016.02.003 27069865
33. Blanche P, Dartigues JF, Jacqmin-Gadda H, Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat Med. 2013;32:5381–97. doi: 10.1002/sim.5958 24027076
34. Guinney J, Wang T, Laajala TD, Winner KK, Bare JC, Neto EC, et al. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. Lancet Oncol. 2017;18:132–42. doi: 10.1016/S1470-2045(16)30560-5 27864015
35. Kass RE, Raftery AE, Bayes factors. J Am Stat Assoc. 1995;90:773–95.